UK scientists have pioneered a new method for profiling the microbiome of preterm babies that can significantly speed up the identification of infections and indicate more effective treatments.
By combining single-cell analysis techniques with machine learning algorithms, researchers have developed a method to 'fingerprint' human cells.
scATAC-seq technology provides unprecedented opportunity to study the impact of epigenetic changes on development and disease.
Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale genome assembly and metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture.
Next-generation sequencing facility Micromon Genomics is the first Australian commercial user of the high-throughput genetic sequencer MGISEQ-2000.
Tecan has launched NGS DreamPrep, a fully automated approach to next-generation sequencing (NGS) library preparation for research use.
High-quality libraries are key to keeping next-generation sequencing maximising usable data.
Researchers from Newcastle University are investigating the genetic causes of male infertility — an often-overlooked condition about which very little is known.
When it comes to cancer treatment, tumour mutational burden has become increasingly utilised as a biomarker for immunotherapy response prediction.
The four new genes contribute to the devastating neurological disease, multiple sclerosis (MS).
The UK's 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes, just over five years after it was announced by then Prime Minister David Cameron.
GeneCopoeia's Genome-CRISP CRISPR-Cas9 products and services are designed to provide a complete, powerful solution for precision RNA-guided genome editing.
GeneCopoeia's AAVPrime adeno-associated virus (AAV) products are useful tools for inserting genes into a broad range of cell types with high efficiency and enhanced safety.
Lunatic from Unchained Labs makes batch quantification of protein, DNA and RNA simple. It is said to be the easiest-to-use system on the market that can batch measure biologics and genomics from low to high concentrations due to its dynamic range of 0.03–200 OD.
A good beer is all about the yeast, but can next-generation sequencing lead to a better brew?